Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories

Company news

ABL Diagnostics Webinar Series - Session II

INTRODUCING THE DEEPCHEK GENOTYPING TECHNOLOGY

OVERVIEW & USERS EXPERIENCE

Webinar from Tuesday January 30, 2024 – 4pm CET

Revue de la Solution DeepChek Genotyping à travers un Webinaire présenté par notre équipe et par un panel d'experts :

  • "Introduction to the DeepChek Assays & Software" (ABL Diagnostics)
  • "Scaling up Genomic Surveillance:  An end-to-end workflow for NGS targeting Infectious Diseases." (Dr. Graziella Zhara, Mater Dei Hospital, Malta) - cancelled (personal reasons)
  • "The transition from Sanger-based sequencing to NGS for HIV-1 drug resistance genotyping in a diagnostic environment" (Dr. Lütgehetmann, Universitätsklinikum Hamburg-Eppendorf, Germany)
https://youtu.be/Q6pyn_U-Gtg
See all